CervoMed to Participate in Upcoming Investor Conferences
CervoMed Inc. (CRVO)
Company Research
Source: GlobeNewswire
BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the Company’s management will participate in the following investor conferences during the month of September: Morgan Stanley 22nd Annual Global Healthcare ConferenceFormat: Fireside ChatDate: Friday, September 6, 2024Time: 1:50 PM ETWebcast Link: click here H.C. Wainwright 26th Annual Global Investment ConferenceFormat: Corporate PresentationDate: Wednesday, September 11, 2024Time: 8:30 AM ETWebcast Link: click here The webcast of these presentations will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/. About CervoMedCervoMed Inc. (the “Company”) is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is currently developing neflamapimod, an investigational, orally administered small molecule brain
Show less
Read more
Impact Snapshot
Event Time:
CRVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRVO alerts
High impacting CervoMed Inc. news events
Weekly update
A roundup of the hottest topics
CRVO
News
- CervoMed Inc. (NASDAQ: CRVO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.MarketBeat
- CervoMed Announces Key Senior Leadership AppointmentsGlobeNewswire
- CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- CervoMed Awarded the Prix Galien USA 2024 Prize for Best StartupGlobeNewswire
- CervoMed to Participate in Upcoming Investor ConferencesGlobeNewswire
CRVO
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- 11/12/24 - Form 10-Q
- CRVO's page on the SEC website